Table 2 Basic patient characteristics of the clinical data set (MARS study)
Training data (N = 817) | Validation data (N = 205) | Overall (N = 1,022) | p | |
|---|---|---|---|---|
Gender | ||||
Female | 431 (52.8%) | 105 (51.2%) | 536 (52.4%) | 0.753 |
Male | 386 (47.2%) | 100 (48.8%) | 486 (47.6%) | |
Age | ||||
Mean (SD) | 47.4 (14.0) | 47.1 (14.4) | 47.3 (14.1) | 0.790 |
[Min, Max] | [18.0, 85.0] | [18.0, 87.0] | [18.0, 87.0] | |
Diagnosis (ICD-10) | ||||
F32 | 289 (35.4%) | 61 (29.8%) | 350 (34.2%) | 0.152 |
F33 | 528 (64.6%) | 144 (70.2%) | 672 (65.8%) | |
HDRS-17 baseline sum score | ||||
Mean (SD) | 24.0 (5.6) | 23.4 (5.5) | 23.8 (5.6) | 0.185 |
[Min, Max] | [12.0, 40.0] | [10.0, 39.0] | [10.0, 40.0] | |
Missing | 11 (1.3%) | 4 (2.0%) | 15 (1.5%) | |
HDRS-17 response | ||||
Yes | 454 (55.6%) | 110 (53.7%) | 564 (55.2%) | 0.679 |
No | 363 (44.4%) | 95 (46.3%) | 458 (44.8%) | |